Tacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally, 500 090, INDIA, NDC 55111-526-01
Published January 17, 2024 · Recall initiated: December 15, 2023
Summary
FDA records drug Class II recall D-0219-2024, published January 17, 2024 and initiated December 15, 2023. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 8,280 bottles; Lot: Lot# C2307275; Exp. January 2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.
What to do
Voluntary: Firm initiated · Letter
Get an email if TACROLIMUS has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TACROLIMUS
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- US Nationwide.
- UPC
- 0355111527015
- Lot
- Lot# C2307275; Exp. January 2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGenJanuary 17, 2024
- FDAVitality Polyaxial Screw, 7.5mmx 50mm, REF: 07.02000.118, used with Vitality and Vital Spinal Fixation SystemJanuary 10, 2024
- FDATacrolimus Capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Mfd. by Dr. Reddy's Laboratories Limited,March 1, 2023
- FDATacrolimus Ointment, 0.1%, For Dermatological Use Only, Not for Ophthalmic Use, Rx Only, a) 30 g tube, NDCAugust 10, 2022
- FDATacrolimus Capsules, USP 5mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDCApril 1, 2020
- FDATacrolimus Capsules, USP, 0.5 mg, 100 capsules/bottle, Rx only, Manufactured in India by Sandoz Private ltd.January 1, 2014
Questions about this recall
Was Tacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally, 500 090, INDIA, NDC 55111-526-01 recalled?
Yes. FDA published recall D-0219-2024 on January 17, 2024. Reported hazard: Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TACROLIMUS. UPC: 0355111527015.